Daiken Biomedical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	2,236	1,140	287.07	243.71
Cash & Short-Term Investments	2,236	1,140	287.07	243.71
Cash Growth	96.21%	297.03%	17.79%	-
Accounts Receivable	136.32	93.5	68.19	53.54
Other Receivables	7.27	0.65	3.33	-
Receivables	143.59	94.15	71.51	53.54
Inventory	416	245.71	262.65	178.36
Prepaid Expenses	41.41	31.89	19.39	17.58
Other Current Assets	3,026	-	92.12	30.71
Total Current Assets	5,863	1,511	732.73	523.9
Property, Plant & Equipment	19.25	3.28	-	-
Other Intangible Assets	3.96	3.74	1.46	1.09
Long-Term Deferred Tax Assets	13.07	11.69	6.53	-
Other Long-Term Assets	13.3	7.62	4.45	5.18
Total Assets	5,913	1,538	745.17	530.17
Accounts Payable	154.33	73.75	53.15	32.4
Accrued Expenses	80.7	63.24	89.3	87.6
Short-Term Debt	100	-	158	33
Current Portion of Long-Term Debt	-	-	69.02	41.63
Current Portion of Leases	3.2	1.82	-	-
Current Income Taxes Payable	63.92	9.37	28.15	19.36
Current Unearned Revenue	10.18	7.26	30.23	21.46
Other Current Liabilities	34.54	74.93	20.45	5.91
Total Current Liabilities	446.87	230.37	448.29	241.37
Long-Term Debt	-	-	49.56	61.37
Long-Term Leases	15.18	0.45	-	-
Long-Term Deferred Tax Liabilities	7.9	-	-	-
Total Liabilities	469.95	230.81	497.85	302.74
Common Stock	810.02	600.02	155.4	155.4
Additional Paid-In Capital	4,415	624.06	-	-
Retained Earnings	187.38	83.76	91.92	72.03
Comprehensive Income & Other	30.35	-0.86	-	-
Shareholders' Equity	5,443	1,307	247.32	227.43
Total Liabilities & Equity	5,913	1,538	745.17	530.17
Total Debt	118.37	2.27	276.58	136
Net Cash (Debt)	2,118	1,137	10.49	107.71
Net Cash Growth	86.20%	10746.37%	-90.26%	-
Net Cash Per Share	3.17	2.59	0.05	0.69
Filing Date Shares Outstanding	810.02	600.02	155.4	155.4
Total Common Shares Outstanding	810.02	600.02	155.4	155.4
Working Capital	5,416	1,281	284.44	282.53
Book Value Per Share	6.72	2.18	1.59	1.46
Tangible Book Value	5,439	1,303	245.86	226.34
Tangible Book Value Per Share	6.71	2.17	1.58	1.46

Source: S&P Global Market Intelligence. Standard template. Financial Sources.